ELEVATE YOUR CARE WITH RHINAER®
Target the multiple sources of chronic rhinitis for lasting relief
RhinAer Treats the Root Causes of Chronic Rhinitis
RhinAer addresses the underlying causes of rhinorrhea, post-nasal drip and congestion in a single session making it the only truly comprehensive procedure to:
- Disrupt the posterior nasal nerves (PNN) that trigger rhinitis
- Treat soft tissue anatomic contributors to congestion, including the full length of the inferior turbinates and septal swell body
Innovative, Office-friendly Technology with Proven Symptom Relief
The Aerin® Console and the RhinAer Stylus are compact and portable, designed to seamlessly integrate into any clinic, office, or hospital environment.
Using temperature-controlled radiofrequency (TCRF) ablation, the RhinAer Stylus employs proprietary technology optimized for the nasal airway resulting in lasting improvement of symptoms.1-3 RhinAer’s TCRF technology senses and adjusts power output to maintain a consistent tissue temperature.
Comprehensive Treatment in the Office or Operating Room
The RhinAer procedure is non-invasive, comprehensive and ideal for an office setting:
- It can be performed using local anesthesia during a routine office visit
- The procedure targets two treatment zones: zone one disrupts the PNN, while zone two addresses the inferior turbinate and septal swell body to alleviate congestion
- Each treatment cycle lasts for 12 seconds
Endorsements of PNN Ablation for Treating Chronic Rhinitis:
Both the American Academy of Otolaryngology – Head and Neck Surgery and the American Rhinologic Society support the use of PNN ablation to improve the symptoms of chronic rhinitis.
This procedure…should be considered as an effective option in treating chronic rhinitis and improving patient quality of life in those suffering from rhinorrhea and nasal congestion.
American Rhinologic Society, January 2022
…The AAO endorses the use of PNN ablation for the treatment of medically-refractory chronic rhinitis. We do not consider these treatments to be experimental.
AAO-HNSF, January 2023
WEB1323-25.A
Disclaimer
The RhinAer® Stylus is indicated for use in otorhinolaryngology (ENT) surgery for the destruction of soft tissue in the nasal airway, including in posterior nasal nerve regions in patients with chronic rhinitis.
Specific indications, contraindications, warnings, precautions, and safety information exist for these products. Aerin Medical relies on the physician to determine, assess and communicate to each patient all foreseeable risks of the procedure. A physician must always refer to the package insert, product label and/or instructions for use before using any of Aerin Medical’s products. Rx only.
References:
- Ehmer D, McDuffie CM, McIntyre JB, Davis BM, Mehendale NH, Willis JH, Watkins JP, Kakarlapudi VV. Long-term Outcomes Following Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Chronic Rhinitis. Allergy Rhinol (Providence). 2022 May 29;13:21526575221096045. doi: 10.1177/21526575221096045. PMID: 35663498; PMCID: PMC9158436. https://pmc.ncbi.nlm.nih.gov/articles/PMC9158436/
- Lee, J.T., Abbas, G.M., Charous, D.D., Cuevas, M., Göktas, Ö., Loftus, P.A., Nachlas, N.E., Toskala, E.M., Watkins, J.P. and Brehmer, D. (2023), Two-Year Outcomes After Radiofrequency Neurolysis of Posterior Nasal Nerve in Chronic Rhinitis. The Laryngoscope. https://onlinelibrary.wiley.com/doi/10.1002/lary.31120
- Takashima M, Stolovitzky JP, Ow RA, et al. Temperature-controlled radiofrequency ablation for the treatment of chronic rhinitis: Two-year outcomes from a prospective multicenter trial. Int Forum Allergy Rhinol. 2024; 1-13. https://onlinelibrary.wiley.com/doi/10.1002/alr.23315